Related Experiment Video
Updated: Mar 14, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Rational Polytherapy with Antiepileptic Drugs
Jong Woo Lee1, Barbara Dworetzky2
1The Edward B. Bromfield Epilepsy Program, Division of EEG, Epilepsy, and Sleep Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. jlee38@partners.org.
Many patients require more than one antiepileptic drug (AED) for seizure control. This review explores rational polytherapy strategies, combining AEDs for improved efficacy and safety in epilepsy treatment.
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy affects millions worldwide, with a significant portion of patients (30-40%) unresponsive to monotherapy with a single antiepileptic drug (AED).
- The development of numerous AEDs over the last 15 years has created opportunities for combination therapies.
Approach:
- This review synthesizes theoretical considerations regarding AED mechanisms of action.
- It examines evidence from animal models and human studies investigating AED combinations.
- Challenges and practical aspects of implementing rational polytherapy are discussed.
Key Points:
- Rational polytherapy aims to combine AEDs with complementary mechanisms to enhance seizure control.
- Optimal combinations require careful consideration of drug interactions, side effect profiles, and patient-specific factors.
- Case scenarios illustrate successful rational polytherapy approaches in clinical practice.
Conclusions:
- Rational polytherapy represents a crucial strategy for managing refractory epilepsy.
- Further research is needed to optimize AED combinations and improve patient outcomes.
More Related Videos
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...